Objectives:
-Determine whether a biomarker is prognostic or predictive
-Describe the current state of biomarkers of prognosis and for predicting treatment response in JDM/DM
-Understand how treatment response is measured in research studies of JDM/DM
-Describe why gene expression at diagnosis may be a good biomarker for prognosis and predicting treatment response
-Learn what RNA sequencing is and how it differs from microarrays for measuring gene expression
-Recognize some general approaches to analyzing gene expression data and their strengths and weaknesses
Location:
Durham, NC
United States
See map: Google Maps
Add to calendar:
Session date:
05/21/2019 - 8:00am to 9:00am EDT
Room Number:
3031
Speaker Name:
Cory Stingl, MD

Facebook
X
LinkedIn
Forward